We have recently shown that CDK4/6 inhibition activates the p53 tumour suppressor in melanoma cells by reducing expression of the p53-inhibitor MDM4 [25], and here we extend this observation by demonstrating a role for p53 in the adaptive metabolic response to CDK4/6 inhibition. The gene discussed is MDM4; the disease is melanoma.